Defense Biotechnology Strategy Act

The Defense Biotechnology Strategy Act (HR 6009) requires the U.S. Department of Defense (DoD) to create a comprehensive strategy within one year of enactment, detailing how biotechnology will support national security. The strategy must address specific areas including developing commercial biomanufacturing facilities for defense-critical products, updating military specifications to use biotech-based items, establishing advance market commitments for biotech products, integrating biotechnology into military exercises, and enhancing international cooperation with NATO allies on biotechnology procurement and research. This bill directly affects DoD operations, defense contractors, and U.S. partnerships with NATO countries. It mandates concrete planning steps but does not create new funding or alter existing laws.